世界のガンマアミノ酪酸受容体サブユニットガンマ2市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)

GlobalInfoResearchが発行した調査報告書(GIR21JY00001)
◆英語タイトル:Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market 2021 by Company, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21JY00001
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年7月(※2024年版があります。お問い合わせください。)
◆ページ数:80
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

GlobalInfoResearch社の本調査レポートでは、ガンマアミノ酪酸受容体サブユニットガンマ2の世界市場を広く調査・分析し、今後の市場展望をまとめております。ガンマアミノ酪酸受容体サブユニットガンマ2の種類別市場規模(EL-001、LASSBio-785、LASSBio-786、塩酸ミダゾラム、その他)、用途別市場規模(全身麻酔効果、不眠症、高血圧症、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Jiangsu Hengrui Medicine Co Ltd、Jiangsu Nhwa Pharmaceutical Corp Ltd、Paion AG、Pfizer Inc、Primex Pharmaceuticals Oy、Takeda
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:EL-001、LASSBio-785、LASSBio-786、塩酸ミダゾラム、その他
・用途別分析2016年-2026年:全身麻酔効果、不眠症、高血圧症、その他
・ガンマアミノ酪酸受容体サブユニットガンマ2の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・ガンマアミノ酪酸受容体サブユニットガンマ2のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・ガンマアミノ酪酸受容体サブユニットガンマ2のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・ガンマアミノ酪酸受容体サブユニットガンマ2の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・ガンマアミノ酪酸受容体サブユニットガンマ2の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
EL-001
LASSBio-785
LASSBio-786
Midazolam Hydrochloride
Others

Market segment by Application, can be divided into
General Anesthetic Effect
Insomnia
Hypertension
Others

Market segment by players, this report covers
Jiangsu Hengrui Medicine Co Ltd
Jiangsu Nhwa Pharmaceutical Corp Ltd
Paion AG
Pfizer Inc
Primex Pharmaceuticals Oy
Takeda

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2, with revenue, gross margin and global market share of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 from 2019 to 2021.
Chapter 3, the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Product Overview and Scope of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2
1.2 Classification of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 by Type
1.2.1 Overview: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Market Share by Type in 2020
1.2.3 EL-001
1.2.4 LASSBio-785
1.2.5 LASSBio-786
1.2.6 Midazolam Hydrochloride
1.2.7 Others
1.3 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market by Application
1.3.1 Overview: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 General Anesthetic Effect
1.3.3 Insomnia
1.3.4 Hypertension
1.3.5 Others
1.4 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size & Forecast
1.5 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast by Region
1.5.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Region, (2016-2021)
1.5.3 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Prospect (2016-2026)
1.5.4 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Prospect (2016-2026)
1.5.6 South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Drivers
1.6.2 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Restraints
1.6.3 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Trends Analysis
2 Company Profiles
2.1 Jiangsu Hengrui Medicine Co Ltd
2.1.1 Jiangsu Hengrui Medicine Co Ltd Details
2.1.2 Jiangsu Hengrui Medicine Co Ltd Major Business
2.1.3 Jiangsu Hengrui Medicine Co Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product and Solutions
2.1.4 Jiangsu Hengrui Medicine Co Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Jiangsu Hengrui Medicine Co Ltd Recent Developments and Future Plans
2.2 Jiangsu Nhwa Pharmaceutical Corp Ltd
2.2.1 Jiangsu Nhwa Pharmaceutical Corp Ltd Details
2.2.2 Jiangsu Nhwa Pharmaceutical Corp Ltd Major Business
2.2.3 Jiangsu Nhwa Pharmaceutical Corp Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product and Solutions
2.2.4 Jiangsu Nhwa Pharmaceutical Corp Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Jiangsu Nhwa Pharmaceutical Corp Ltd Recent Developments and Future Plans
2.3 Paion AG
2.3.1 Paion AG Details
2.3.2 Paion AG Major Business
2.3.3 Paion AG Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product and Solutions
2.3.4 Paion AG Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Paion AG Recent Developments and Future Plans
2.4 Pfizer Inc
2.4.1 Pfizer Inc Details
2.4.2 Pfizer Inc Major Business
2.4.3 Pfizer Inc Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product and Solutions
2.4.4 Pfizer Inc Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Pfizer Inc Recent Developments and Future Plans
2.5 Primex Pharmaceuticals Oy
2.5.1 Primex Pharmaceuticals Oy Details
2.5.2 Primex Pharmaceuticals Oy Major Business
2.5.3 Primex Pharmaceuticals Oy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product and Solutions
2.5.4 Primex Pharmaceuticals Oy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Primex Pharmaceuticals Oy Recent Developments and Future Plans
2.6 Takeda
2.6.1 Takeda Details
2.6.2 Takeda Major Business
2.6.3 Takeda Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product and Solutions
2.6.4 Takeda Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Takeda Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Players Market Share
3.2.2 Top 10 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Players Market Share
3.2.3 Market Competition Trend
3.3 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Market Share by Type (2016-2021)
4.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Market Share by Application (2016-2021)
5.2 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2016-2026)
6.2 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2016-2026)
6.3 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country
6.3.1 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2016-2026)
6.3.2 United States Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
6.3.3 Canada Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
6.3.4 Mexico Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2016-2026)
7.2 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2016-2026)
7.3 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country
7.3.1 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2016-2026)
7.3.2 Germany Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
7.3.3 France Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
7.3.5 Russia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
7.3.6 Italy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2016-2026)
8.2 Asia-Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2016-2026)
8.3 Asia-Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Region
8.3.1 Asia-Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Region (2016-2026)
8.3.2 China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
8.3.3 Japan Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
8.3.4 South Korea Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
8.3.5 India Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
8.3.7 Australia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2016-2026)
9.2 South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2016-2026)
9.3 South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country
9.3.1 South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2016-2026)
9.3.2 Brazil Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
9.3.3 Argentina Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2016-2026)
10.2 Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2016-2026)
10.3 Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country
10.3.1 Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2016-2026)
10.3.2 Turkey Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
10.3.4 UAE Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

...

【掲載企業】

Jiangsu Hengrui Medicine Co Ltd、Jiangsu Nhwa Pharmaceutical Corp Ltd、Paion AG、Pfizer Inc、Primex Pharmaceuticals Oy、Takeda

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のガンマアミノ酪酸受容体サブユニットガンマ2市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)(Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market 2021 by Company, Regions, Type and Application, Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。